Jim Cramer’s Charitable Trust is selling 475 shares of TJX Companies at roughly $135 and reallocating the proceeds into Kimberly-Clark and Constellation Brands, reducing its exposure to an off-price retailer facing renewed questions about its largest U.S. Division. The trades leave the trust with 500 TJX shares, lowering the position’s portfolio weighting to about 1.8% from 3.4%. The sale is expected to produce an average gain of about 113% on TJX shares purchased in August 2022 and March 2023.
The decision followed Gordon Haskett’s downgrade of TJX to hold with a $130 price target on Nov. The firm cited competitive pressure from Ross Stores and continuing execution issues at Marmaxx, the segment that includes TJ Maxx, Marshalls and Sierra.
TJX’s second-quarter results explain why Marmaxx has become the focus of the debate. For the quarter ended Aug.
The remaining funds are being allocated relatively evenly to Constellation Brands.
Analysis: The trades shift capital away from a position whose near-term test is concentrated in Marmaxx and toward two companies with different operating catalysts identified in the available disclosures: Kimberly-Clark’s integration of Kenvue and Constellation’s improving beer shipments and share performance.
